Abstract:Graphical and Lay Summary Two parameters are particularly critical when developing manufacturing cell lines: short timelines and high productivity. This study demonstrates the possibility to concomitantly reduce the timelines by using low viability pools and increase the productivity of the clones by using cold capture, an immunostaining protocol used for two decades. Using Beacon, we validated the positive impact of cold capture on titers and specific productivities. Furthermore, we showed that combining an early sorting with cold capture protocol systematically increased Qp of cells in batch assays. The method developed in this study provides valuable improvement for cell line development workflows. Improving current cell line development workflows can either focus on increasing the specific productivity of the cell lines or shortening timelines to reach the clinic as fast as possible. In this work, using the Beacon platform, we have combined two distinct protocols – early cloning with low‐viability pools, and IgG membrane staining‐, to concomitantly reach both objectives, and generate highly productive CHO clones in shorter timelines. Fast‐sorting approaches using low‐viability pools in combination with the Beacon platform have recently been reported to shorten CLD timelines. However, the low recovery led to a drastic reduction in the clone number obtained postcloning. Here, we report a combined approach of fast‐sorting and fluorescent membrane staining. With this new protocol, the cells reach a correct recovery, allowing to fully exploit the Beacon screening capacities. In addition, by using a fluorescent staining recognizing the secreted IgG, we were able to enrich the fraction of highly secreting cells prior to cloning and we obtained significant increases in the cell's specific productivity. The combination of these two protocols has a synergistic effect, and as they help discarding the dead and nonproducing populations prior to cloning, they increase the throughput power of the Beacon platform and the detection of super productive clones.

Dynamic Ranking of Clones with Process Conditions Using a High-Throughput Micro-bioreactor Platform

An automated high inoculation density fed-batch bioreactor, enabled through N-1 perfusion, accommodates clonal diversity and doubles titers

Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning

Transcriptomics and cell painting analysis reveals molecular and morphological features associated with fed-batch production performance in CHO recombinant clones

A Two-Phase Approach Optimizing Productivity for a mAb-producing CHO Cell Culture Process Using Dynamic Response Surface Methodology Models

Performance benchmark of different cell clones in discontinuous and continuous bioprocesses reveals critical impact of cellular diameter

Productive CHO cell lines selection in biopharm process development through machine learning on metabolomic dynamics

Combined approach of selective and accelerated cloning for microfluidic chip‐based system increases clone specific productivity

Microfluidic chip‐based single‐cell cloning to accelerate biologic production timelines

Selection of CHO host cell subclones with increased specific antibody production rates by repeated cycles of transient transfection and cell sorting

Developing the biofacility of the future based on continuous processing and single-use technology

Generation of reference cell lines, media, and a process platform for CHO cell biomanufacturing

Coupling picodroplet microfluidics with plate imaging for the rapid creation of biomanufacturing suitable cell lines with high probability and improved multi-step assurance of monoclonality

A novel hybrid bioprocess strategy addressing key challenges of advanced biomanufacturing

Development and Qualification of a Scale-Down Mammalian Cell Culture Model and Application in Design Space Development by Definitive Screening Design

Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior

Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production

High‐throughput and automation advances for accelerating single‐cell cloning, monoclonality and early phase clone screening steps in mammalian cell line development for biologics production

From Discovery to Delivery: A Rapid and Targeted Proteomics Workflow for Monitoring Chinese Hamster Ovary Biomanufacturing

Impact of fed-batch process intensification on the productivity and product quality of two CHO cell lines expressing unique novel molecular format proteins

Downscaling screening cultures in a multifunctional bioreactor array‐on‐a‐chip for speeding up optimization of yeast‐based lactic acid bioproduction